Copyright
        ©2014 Baishideng Publishing Group Co.
    
    
        World J Gastroenterol. Jan 14, 2014; 20(2): 401-413
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.401
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.401
		Figure 1 Progress in the field of hepatitis B virus.
		
			 HBV: Hepatitis B virus; HBeAg: Hepatitis B e antigen; HCC: Hepatocellular carcinoma.
		
	
		Figure 2 Five phases of chronic hepatitis B.
		
			 Adapted from Tong et al[37]. ALT: Alanine aminotransferase; Anti-HBc: Hepatitis B core antibody; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; Anti-HBe: Hepatitis B e antibody.
		
	
		Figure 3 Timeline of approved therapies for chronic hepatitis B.
		
			 IFN: Interferon.
		
	
		Figure 4 Characteristics of approved drugs for treatment of hepatitis B.
		
			
		
	
- Citation: Marzio DHD, Hann HW. Then and now: The progress in hepatitis B treatment over the past 20 years. World J Gastroenterol 2014; 20(2): 401-413
- URL: https://www.wjgnet.com/1007-9327/full/v20/i2/401.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i2.401

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                         
                         
			 
			 
			